Walgreens Boots Alliance (WBA) agreed to pay over $2.8 million to settle allegations that it violated federal, Massachusetts and Georgia laws by submitting inflated prices for certain generic medications to the states' Medicaid programs, the US Attorney's Office for the District of Massachusetts said Thursday.
Walgreens' pharmacies allegedly submitted a higher "usual and customary price" to the MassHealth and Georgia Medicaid programs for certain generic medicines between 2008 and 2023.
The settlement resolves, in part, allegations brought by a whistleblower, according to the press release.
Walgreens did not immediately respond to MT Newswires' request for comment.
Price: 11.16, Change: +0.05, Percent Change: +0.50
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。